Glycadia
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1880 John F Kennedy Blvd Ste 200, Philad...Phone Number
(215) 557-8021Website
www.glycadia.comRevenue
<$5 MillionIndustry
About Glycadia
Glycadia Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular, and related diseases stemming from diabetes. The company aims to address the significant healthcare needs of over 100 million individuals in the United States who suffer from diabetes-related complications. Glycadia's product pipeline includes innovative compounds such as GLY-230, GLY-220, and A717 mAb, targeting diabetic nephropathy, macrovascular, and microvascular diseases. With a commitment to discovery, Glycadia is advancing its clinical trials to bring effective solutions to patients at risk.Explore more
Glycadia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Glycadia
Compare insights from companies similar to Glycadia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Glycadia Tech Stack
A closer look at the technologies used by Glycadia
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Glycadia
Sign Up For FreeTo access detailed company insights
Glycadia Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular, and related diseases stemming from diabetes. The company aims to address the significant healthcare needs of over 100 million individuals in the United States who suffer from diab... Read More
